Sensitive detection of human papillomavirus type 16 E7-specific T cells by ELISPOT after multiple in vitro stimulations of CD8+ T cells with peptide-pulsed autologous dendritic cells

Molecular Cancer

Volumn 5, Issue , 2006, Pages

  Cools, Nathalie ^a   Ponsaerts, Peter ^a   Lenjou, Marc ^a   Nijs, Griet ^a   Van Bockstaele, Dirk R ^a   Van Tendeloo, Viggo F I ^a   Berneman, Zwi N ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; DENDRITIC CELL VACCINE; GAMMA INTERFERON; HLA A2 ANTIGEN; PROTEIN E7;

ANTIGEN SPECIFICITY; ARTICLE; CANCER RESEARCH; CD8+ T LYMPHOCYTE; CELL SPECIFICITY; CELLULAR IMMUNITY; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DONOR; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNE RESPONSE; IMMUNOASSAY; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE; SENSITIVITY ANALYSIS; T LYMPHOCYTE; TUMOR IMMUNITY; UTERINE CERVIX CANCER;

ANTIGENS, VIRAL, TUMOR; CD8-POSITIVE T-LYMPHOCYTES; COCULTURE TECHNIQUES; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOPHENOTYPING; INTERFERON-GAMMA; K562 CELLS; OLIGOPEPTIDES; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 33750807719     PISSN: 14764598     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-5-49     Document Type: Article

References (24)

1. Pisani P, Bray F, Parkin DM: Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 2002, 97:72-81.
2. Parkin DM: Global cancer statistics in the year 2000. Lancet Oncol 2001, 2:533-543.
3. Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P, Favini G, Ferri L, Mangioni C: Randomised study of radical surgery versus radiotherapy for stage Ib-Iia cervical cancer. Lancet 1997, 350:535-540.
4. Thomas GM: Improved treatment for cervical cancer - concurrent chemotherapy and radiotherapy. N Engl J Med 1999, 340:1198-1200.
5. Berger TG, Schultz ES: Dendritic cell-based immunotherapy. Curr Top Microbiol Immunol 2003, 276:169-197.
6. Santini SM, Belardelli F: Advances in the use of dendritic cells and new adjuvants for the development of therapeutic vaccines. Stem Cells 2003, 21:495-505.
7. Jager E, Jager D, Knuth A: Antigen-specific immunotherapy and cancer vaccines. Int J Cancer 2003, 106:817-820.
8. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV: Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995, 87:796-801.
9. Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A, zur Hausen H: Sructure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985, 314:111-114.
10. Munger K, Phelps WC, Bubb V, Howley PM, Schlegel R: The E6 and E7 genes of human papillomavirus type 16 are necessary and sufficient for transformation of primary human keratinocytes. J Virol 1989, 63:4417-4423.
11. Ressing ME, van Driel WJ, Celis E, Sette A, Brandt MP, Hartman M, Anholts JD, Schreuder GM, ter Harmsel WB, Fleuren GJ, Trimbos BJ, Kast WM, Melief CJ: Occasional memory cytotoxic T cell responses of patients with human papillomavirus type 16-positive cervical lesions. Cancer Res 1996, 56:582-588.
12. Evans EM, Man S, Evans AS, Borysiewicz LK: Infiltration of cervical cancer tissue with human papillomavirus-specific cytotoxic T-lymphocytes. Cancer Res 1997, 57:2943-2950.
13. Ressing ME, Sette A, Brandt RM, Ruppert J, Wentworth PA, Hartman M, Oseroff C, Grey HM, Melief CJ, Kast WM: Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies. J Immunol 1995, 154:5934-5943.
14. Schoell WM, Mirhashemi R, Liu B, Janicek MF, Podack ER, Penalver MA, Averette HE: Generation of tumor-specific cytotoxic T lymphocytes by stimulation with HPV type 16 E7 peptide-pulsed dendritic cells: an approach to immunotherapy of cervical cancer. Gynecol Oncol 1999, 74:448-55.
15. Nonn M, Schinz M, Zumbach K, Pawlita M, Schneider A, Durst M, Kaufmann AM: Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16 E7 or HPV18 E7. J Cancer Res Clin Oncol 2003, 129:511-20.
16. Ferrara A, Nonn M, Sehr P, Schreckenberger C, Pawlita M, Durst M, Schneider A, Kaufmann AM: Dendritic cell-based tumor vaccine for cervical cancer II: results of a clinical pilot study in 15 individual patients. J Cancer Res Clin Oncol 2003, 129:521-30.
17. Herbst B, Lindemann A: Dendritic cells for immunotherapy. Biomedical Progress 1998, 11:1-6.
18. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 1998, 392:245-252.
19. Matzinger P: The danger model: A renewed sense on self. Science 2002, 296:301-5.
20. Romani N, Gruner S, Brang D, Kampgen E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM, Schuler G: Proliferating dendritic cell progenitors in human blood. J Exp Med 1994, 180:83-93.
21. Ponsaerts P, Van Tendeloo VF, Cools N, Van Driessche A, Lardon F, Nijs G, Lenjou M, Mertens G, Van Broeckhoven C, Van Bockstaele DR, Berneman ZN: mRNA-electroporated mature dendritic cells retain transgene expression, phenotypical properties and stimulatory capacity after cryopreservation. Leukemia 2002, 16:1324-30.
22. Jonuleit H, Kuhn U, Muller G, Steinbrink K, Paragnik L, Schmitt E, Knop J, Enk AH: Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 1997, 27:3135-42.
23. Britten CM, Meyer RG, Kreer T, Drexler I, Wolfel T, Herr W: The use of HLA-A*0201-transfected K562 as standard antigen-presenting cells for CD8(+) T lymphocytes in IFN-gamma ELISPOT assays. J Immunol Methods 2002, 259:95-110.
24. Tanguay S, Killion JJ: Direct comparison of ELISPOT and ELISA-based assay for detection of individual cytokine-secreting cells. Lymphokine Cytokine Res 1994, 13:259-263.